• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clinical significance of islet protein presented by type 1 diabetes-susceptible

Research Project

Project/Area Number 14571117
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionOkinaka Memorial Institute for Medical Research

Principal Investigator

NAKANISHI Koji  Okinaka Memorial Institute for Medical Research, Staff, 研究員 (80211423)

Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2003: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2002: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsType 1 diabetes / MHC molecule / Antigenic peptides / Islet
Research Abstract

Susceptibility to type 1 diabetes is conferred by major histocompatibility antigens (MHC) and it is caused by T -cell mediated autoimmunity to pancreatic islet. The aim of this study is to identify islet-derived autoantigen which is presented by type 1 diabetes-susceptible MHC molecules. B lymphoblastoid cell lines were prepared from a type 1 diabetic patient and cultured to 10^<10> cells. The debris of fetal islet cell line (1B2C6) were added to one culture system, and the other culture was performed in media only. Cell surface proteins were obtained with treatment of lysis buffer containing NP-40. HLA-DR and --DQ molecules were obtained by affinity chromatography. After treatment of trifluoloacetic acid, the peptides in MHC molecules were analyzed by reverse phase HPLC. Comparing HPLC patterns identified 3 peaks which were specifically emerged under the pulse of the debris of 1B2C6. By sequencing the amino acids, we identified a peptide and their derived protein as heparin sulfate/heparin interacting protein (HIP). We could obtain cDNA of HIP from 1B2C6 cell lines by RT-PCR and expressed HIP protein in E. coli. Autoantibodies to HIP was not detected in type 1 diabetic patients by Western blotting. However, immunostaining of pancreatic section using antisera to HIP revealed specific localization of HIP in the islet. We identified the peptide that naturally processed and presented by type 1 diabetes-susceptible HLA molecule, DR4.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi